Zions Bancorporation N.A. Purchases New Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Zions Bancorporation N.A. purchased a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the third quarter, HoldingsChannel reports. The fund purchased 13,060 shares of the company’s stock, valued at approximately $828,000.

A number of other hedge funds have also bought and sold shares of the company. GAMMA Investing LLC increased its position in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after acquiring an additional 241 shares during the last quarter. Blue Trust Inc. raised its position in Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after buying an additional 248 shares during the last quarter. Commonwealth Equity Services LLC raised its position in Acadia Healthcare by 3.5% during the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after buying an additional 257 shares during the last quarter. Atria Investments Inc raised its position in Acadia Healthcare by 4.7% during the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock worth $434,000 after buying an additional 308 shares during the last quarter. Finally, KBC Group NV grew its stake in shares of Acadia Healthcare by 14.4% during the 3rd quarter. KBC Group NV now owns 2,688 shares of the company’s stock worth $170,000 after purchasing an additional 338 shares during the period.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $39.36 on Friday. Acadia Healthcare Company, Inc. has a twelve month low of $39.27 and a twelve month high of $87.77. The firm has a fifty day simple moving average of $58.83 and a 200 day simple moving average of $65.92. The company has a market capitalization of $3.66 billion, a PE ratio of 12.90, a P/E/G ratio of 1.78 and a beta of 1.33. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same quarter last year, the firm earned $0.91 earnings per share. Acadia Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. On average, sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ACHC. KeyCorp initiated coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research note on Friday, September 20th. Deutsche Bank Aktiengesellschaft upped their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Barclays reduced their target price on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research report on Monday, September 30th. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $86.67.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.